VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Aug 14, 2018
Document Date
Aug 13, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Williams Timothy
Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |